Quantcast

Latest Uric acid Stories

2010-03-15 08:41:00

EAST BRUNSWICK, N.J., March 15 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are...

2010-03-12 07:30:00

SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), today reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010. "Having already confirmed RDEA594's single-agent potential...

2010-03-01 09:10:00

EXTON, Pa., March 1 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends(®): Gout and Hyperuricemia publication. The report is based on responses to online surveys completed by 120 Rheumatologists and 57 Primary Care Physicians in the US who are managing a high number of patients with gout. This syndicated report provides comprehensive insight into how physicians classify patients with gout, how treatment is...

2010-02-17 08:00:00

SAN ANTONIO, Feb. 17 /PRNewswire/ -- Mission Pharmacal Company announced today the introduction of the Urocit®-K 15 mEq (potassium citrate) Extended-release tablet. The new formulation builds on the heritage of Urocit-K with a maximum-strength alkalinizing agent to help prevent kidney stone recurrence in more than 90 percent of patients. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/urocit-k/42386/ "The...

2010-02-16 09:22:09

Simple urine tests for four proteins might be able to detect early kidney disease in people with lupus, researchers at UT Southwestern Medical Center have found in an animal study. Although it might take years before such tests could be used clinically, the findings suggest they could pinpoint kidney disease better than tests currently in use, the researchers said. "Our goal was to accurately detect something in the urine that appears only in disease," said Dr. Chandra Mohan, professor of...

2010-02-08 07:40:32

Independent risk of gout on the risk of acute myocardial infarction among elderly women: A population-based study Women with gout are at greater risk of a heart attack than men with the disease, indicates research published ahead of print in the Annals of the Rheumatic Diseases. Gout is known to boost the risk of a heart attack in men. But to date, little has been known about the impact of gout on women's cardiovascular health. Gout is common and caused by inflammation in the joints as a...

2010-01-11 20:59:31

Small amounts of lead in the bodies of healthy children and teens "” amounts well below the levels defined as "concerning" by the U.S. Centers for Disease Control and Prevention (CDC) "” may worsen kidney function, according to a Johns Hopkins Children's Center study published in the Jan. 11 issue of Archives of Internal Medicine. In 1991, the CDC reduced the lead level "of concern" for children from 30 micrograms to 10 micrograms per deciliter of blood, but the Johns Hopkins...

2010-01-11 07:00:00

WALTHAM, Mass., Jan. 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the U.S. and Europe, a drug that resolves tophi in less than one year would become the patient share leader in the chronic tophaceous gout patient subpopulation and would be used in the vast majority of patients who suffer severe tophaceous gout, according to surveyed U.S. and European rheumatologists. "The...

2010-01-07 07:30:00

SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ --Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced additional positive results from a recently completed Phase 2a study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, as well as additional positive results from the second panel of a Phase 1 drug-drug interaction and pharmacodynamic study of RDEA594 in combination with febuxostat (Uloric®, Takeda Pharmaceutical Company Limited;...

2009-12-01 07:00:00

SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced positive results from the first dosing group of an ongoing drug-drug interaction and pharmacodynamic study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and febuxostat (Uloric®, Takeda Pharmaceutical Company Limited; Adenuric®, Ipsen). This randomized, placebo-controlled study in normal healthy volunteers with baseline...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related